General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Siemens(SIGNIFICANT), Novartis Corporation(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(SIGNIFICANT), Kowa(SIGNIFICANT), 89Bio(MODEST), Amgen(SIGNIFICANT), Roche(MODEST), Kaleido(MODEST), Inozyme(MODEST), emocha health(MODEST) RESEARCH/RESEARCH GRANTS: Amgen Inc.(NONE), Bayer Healthcare Pharmaceuticals(NONE), Novo Nordisk Inc.(NONE)

View Full Disclosure